Magazine

In this issue: Mel Chancey joins us for a conversation on second chances, preventive care, and the pharmacist’s role in what comes next. We also explore how personalization became pharmacy’s best business model in Made to Order, break down The GLP 1 Showdown from TrumpRx and compounding crackdowns to the new era of drug pricing, and look at The Appeal Advantage, including how PBM reform laws can turn into recovered revenue. Plus, we examine why every pharmacy should be prescribing birth control, and spotlight The Pharmacy Top 50 Awards 2025.

Dispense Times (Jan–Feb 2026) explores how pharmacy is evolving—from early e-prescribing to AI-driven workflows—along with key peptide compliance updates for 2026. The cover story looks at the “last 5 feet” of medication delivery and what pharmacies can learn from Mark Cuban’s Cost Plus Drugs model, including impacts on operations, margins, and patient access.